The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 17.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (16 analysts) rates it hold, with a mean price target of $73.
Brown & Brown BRO
Outside both standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Brown & Brown, Inc.
read at $70.95
Brown & Brown holds its Markup at $70.95.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 17 days |
| Price | $70.95 |
| Valuation | 22.67 trailing · 14.71 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.58 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades at roughly a 5% discount to our $74.67 fair value, moderate competitive moat, 32.40% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
| Revenue growth | 32.40% |
| Profit margin | 18.08% |
| Debt to equity | 63.98 |
| Analyst consensus | Hold · 16 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its business activity screen. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Business activity: Financials sector Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Insurance broker fails ethical screen test
Picture every policy sold in America. The broker stands in the middle, skimming a fee while the underwriter takes the real risk. Brown & Brown has lifted revenue 36 percent, yet that growth sits beside a clear ethical fail on the business activity screen.
We pass for that single reason. Forward earnings trade at 14.3 times with an 18 percent profit margin and 12 percent return on equity, numbers that look steady but cannot override the screen. The moderate moat and consensus hold rating near $73 add little once ethics close the door.
Insurance brokerage can turn cyclical fast when rates soften or claims spike. A modest valuation offers no cushion if earnings peak and multiples compress further. Analysis, not advice.
| Forward P/E | 14.7x cheap for a company growing this fast |
| Trailing P/E | 22.7x a premium valuation |
| Revenue growth | 32.4% strong top-line growth |
| Profit margin | 18.1% healthy profit margins |
| Return on equity | 10.0% a modest return on shareholder capital |
| Debt to equity | 0.64 moderate, manageable leverage |
| Current ratio | 1.13 adequate liquidity, worth monitoring |
| Beta | 0.58 steadier than the market |
| Market cap | $23.7B |
| Employees | 22,888 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on BRO
- › Strength Seen in Erie Indemnity (ERIE): Can Its 7.5% Jump Turn into More Strength? Zacks · 29d ago
- › Will Brown & Brown (BRO) Beat Estimates Again in Its Next Earnings Report? Zacks · 16 Jul 2026
- › Brown & Brown (BRO) Faces Mixed Valuation Views, Is The Stock Cheap? Simply Wall St. · 15 Jul 2026
- › Brown & Brown (BRO) Stock Looks Undervalued On Fair Value But Rich On Earnings Simply Wall St. · 15 Jul 2026
- › Brown & Brown Faces Tough Property Quarter With Relief Expected in Q3, Truist Says MT Newswires · 14 Jul 2026
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in BRO's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
BRO trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (16 analysts) rates it hold, with a mean price target of $73.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-06 | MASOJADA BRONISLAW EDMUND | Director | 2,434 | · | |
| 2026-05-06 | SAVIO KATHLEEN A | Director | 2,434 | · | |
| 2026-05-06 | PATEL JAYMIN B | Director | 2,434 | · | |
| 2026-05-06 | KRUMP PAUL J | Director | 2,434 | · | |
| 2026-05-06 | JOHNSON JOIA M | Director | 2,434 | · | |
| 2026-05-06 | MAIN TIMOTHY R M | Director | 2,434 | · | |
| 2026-05-06 | HUNT JAMES S | Director | 2,434 | · | |
| 2026-05-06 | GELLERSTEDT LAWRENCE L III | Director | 2,434 | · | |
| 2026-05-06 | HOEPNER THEODORE J JR | Director | 2,434 | · | |
| 2026-05-06 | REILLY WENDELL S | Director | 2,434 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 30 Jun2026 | Gil Cisneros | Democrat | sell | 1K–15K |
| 3 May2024 | Tommy Tuberville | Republican | sell | 1K–15K |
| 27 May2026 | Ro Khanna | Democrat | buy | 1K–15K |
| 24 Jul2026 | David Taylor | Republican | buy | 1K–15K |
| 2026-04-15 | Richard Blumenthal | Democrat | Purchase | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $55.35 | +8.4% | $0.17 | $1,087 | +8.7% |
| 2 months | $64.89 | -7.5% | $0.17 | $927 | -7.3% |
| 3 months | $67.45 | -11.0% | $0.17 | $892 | -10.8% |
| 6 months | $79.14 | -24.2% | $0.33 | $762 | -23.8% |
| 1 year | $104.56 | -42.6% | $0.65 | $580 | -42.0% |
| 2 years | $88.36 | -32.1% | $1.23 | $693 | -30.7% |
| 3 years | $62.69 | -4.3% | $1.73 | $985 | -1.5% |
| 5 years | $50.37 | +19.1% | $2.58 | $1,243 | +24.3% |
Historical returns from market close data. Past performance does not guarantee future results.